Medical abortion reversal: science and politics meet

被引:7
|
作者
Bhatti, Khadijah Z. [1 ]
Nguyen, Antoinette T. [1 ]
Stuart, Gretchen S. [1 ]
机构
[1] Univ N Carolina, Dept Obstet & Gynecol, Sch Med, Chapel Hill, NC USA
关键词
medical abortion; mifepristone; reversal; MIFEPRISTONE; ACCEPTABILITY; PREGNANCY; SAFETY;
D O I
10.1016/j.ajog.2017.11.555
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Medical abortion is a safe, effective, and acceptable option for patients seeking an early nonsurgical abortion. In 2014, medical abortion accounted for nearly one third (31%) of all abortions performed in the United States. State-level attempts to restrict reproductive and sexual health have recently included bills that require physicians to inform women that a medical abortion is reversible. In this commentary, we will review the history, current evidence-based regimen, and regulation of medical abortion. We will then examine current proposed and existing abortion reversal legislation. The objective of this commentary is to ensure physicians are armed with rigorous evidence to inform patients, communities, and policy makers about the safety of medical abortion. Furthermore, given the current paucity of evidence for medical abortion reversal, physicians and policy makers can dispel bad science and misinformation and advocate against medical abortion reversal legislation.
引用
收藏
页码:315 / +
页数:6
相关论文
共 50 条
  • [21] Abortion "Reversal" - Legislating without Evidence
    Grossman, Daniel
    White, Kari
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (16) : 1491 - 1493
  • [22] Reaching women where they are: eliminating the initial in-person medical abortion visit
    Raymond, Elizabeth G.
    Grossman, Daniel
    Wiebe, Ellen
    Winikoff, Beverly
    CONTRACEPTION, 2015, 92 (03) : 190 - 193
  • [23] Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation
    Lokeland, Mette
    Iversen, Ole Erik
    Engeland, Anders
    Okland, Ingrid
    Bjorge, Line
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2014, 93 (07) : 647 - 653
  • [24] Acceptability of home use of mifepristone for medical abortion
    Swica, Yael
    Chong, Erica
    Middleton, Tamer
    Prine, Linda
    Gold, Marji
    Schreiber, Courtney A.
    Winikoff, Beverly
    CONTRACEPTION, 2013, 88 (01) : 122 - 127
  • [25] Patients' Motivation for Surgical Versus Medical Abortion
    Murray, Marie-Eve
    Casson, Margaret
    Pudwell, Jessica
    Waddington, Ashley
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2019, 41 (09) : 1325 - 1329
  • [26] Medical Abortion at 63 to 90 Days of Gestation
    Lokeland, M.
    Iversen, O. E.
    Dahle, G. S.
    Nappen, M. H.
    Ertzeid, L.
    Bjorge, L.
    OBSTETRICS AND GYNECOLOGY, 2010, 115 (05) : 962 - 968
  • [27] The introduction of first trimester medical abortion in Armenia
    Louie, Karmen S.
    Chong, Erica
    Tsereteli, Tamar
    Avagyan, Gayane
    Vardanyan, Susanna
    Winikoff, Beverly
    REPRODUCTIVE HEALTH MATTERS, 2015, 22 (44) : 56 - 66
  • [28] Medical induced abortion
    Bettahar, K.
    Pinton, A.
    Boisrame, T.
    Cavillon, V.
    Wylomanski, S.
    Nisand, I.
    Hassoun, D.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2016, 45 (10): : 1490 - 1514
  • [29] How do women seeking abortion choose between surgical and medical abortion? Perspectives from abortion service providers
    Newton, Danielle
    Bayly, Chris
    McNamee, Kathleen
    Hardiman, Annarella
    Bismark, Marie
    Webster, Amy
    Keogh, Louise
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2016, 56 (05) : 523 - 529
  • [30] A prospective open-label study of home use of mifepristone for medical abortion in Nepal
    Conkling, Kathryn
    Karld, Chanda
    Tuladhar, Heera
    Bracken, Hillary
    Winikoff, Beverly
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2015, 128 (03) : 220 - 223